Background
The goal of accessing ADME properties is to understand how a potential drug candidate interacts with the human body, including absorption, distribution, metabolism, and excretion. This knowledge is crucial for evaluating efficacy, safety, and clinical potential, guiding drug development for optimal therapeutic outcomes. Fang et al. 2023 has disclosed DMPK datasets collected over 20 months across six ADME in vitro endpoints, which are human and rat liver microsomal stability, MDR1-MDCK efflux ratio, solubility, and human and rat plasma protein binding. The dataset contains 885 to 3087 measures for the corresponding endpoints. The compounds show the chemical diversity across all ranges of the endpoints which are microsomal stability, plasma protein binding, permeability, and solubility.
Description of readout
- Microsomal stability (human and rat):
LOG HLM_CLint (mL/min/kg), LOG RLM_CLint (mL/min/kg)
- Plasma protein binding (human and rat):
LOG PLASMA PROTEIN BINDING (HUMAN) (% unbound), LOG PLASMA PROTEIN BINDING (RAT) (% unbound)
- Permeability:
LOG MDR1-MDCK ER (B-A/A-B)
- Solubility:
LOG SOLUBILITY PH 6.8 (ug/mL)
- Number of molecules after curation: 3516
Data resource
Reference: Prospective Validation of Machine Learning Algorithms for Absorption, Distribution, Metabolism, and Excretion Prediction: An Industrial Perspective
Github: https://github.com/molecularinformatics/Computational-ADME
Raw data: https://github.com/molecularinformatics/Computational-ADME/blob/main/ADME_public_set_3521.csv
Related datasets
Please check out the updated version of this dataset, curated according to the author's advice, available at biogen/adme-fang-v1.
